RheumNow Week in Review – 11 November 2016 Save

Dr Cush reviews highlights from this week on RheumNow.com

1. Lancet reports 10-day bismuth quadruple therapy was superior to 14-day triple therapy for H pylori https://t.co/hSAUvvARjJ
2. Taiwan population study shows among 35k HBV, 10K HCV, 4k dual, only chronic Hep C infx assoc w/ 2 fold risk of #RA… https://t.co/lqEFpbrTLF
3. 275 Italian pts TB screen pre-biologic=10% (+). Rest had annual TBtests, @24 mos 13.6% had 2nd (+)test, no active TB https://t.co/qlIVyur7oI
4. Immune checkpoint inhib. (eg novolumab, ipolimumab) for CA, assoc w/ inflamm arthritis. NEJM report of rhabdo & myocarditis too https://t.co/B6CEXTZCip
5. Metanalysis 71 studies - in IBD, the frequency of sacroiliitis is10%, ankylosing spondylitis 3%, and arthritis 13%. https://t.co/vbBk5jcbum
6. Voclosporin, a new calcineurin inhibitor entering Phase III trials in lupus nephritis https://t.co/yXSp0a9r7v
   Open label RTX in Scleroderma ILD had significant improvement in FVC at 2 yrs, whereas control standard care did not https://t.co/sUdKyhq82F
7. RA erosions dont revert. Dig a hole in the yard-a yr later find twigs, leaves &dog in it;Still a hole. Prolia report https://t.co/qfwz2EZGmZ
8. #AS metabolomics reveal potential biomarkers related to metabolism of fat, intestinal microbes, glucose & choline https://t.co/vjO7YBxtTG
9. The Long Awaited PRECISION Study to be presented at ACR 2016
10. Agressive Early Treatment Prevents Rapid Bone Loss in Rheumatoid Arthritis
11. Enbrel Approved for Pediatric Chronic Plaque Psoriasis